Improving Health and Wellbeing for People Diagnosed With Chronic Spontaneous Urticaria (CSU)
Key facts
- Who runs it
- Royal College of Surgeons, Ireland
- Where
- Ireland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Suspended
- People taking part
- 100 people, planned
- Started
- 1 Jun 2022
- Ended
- 1 Jul 2026
- Type of study
- Interventional, 20 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- ABT Online Programme
- Delayed Control group
- Record updated
- 31 October 2023
- Why it stopped
- Recruitment has been suspended, as we realised the university still had to finish a contract to provide insurance for myself. Therefore, the recruitment was stopped until this is secured.
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Must have diagnosis of CSU
Who cannot take part
- Classified as a vulnerable adult Cannot communicate online, in English
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate the influence of psychosocial factors on Chronic Spontaneous Urticaria (CSU). Preliminary research suggests a potential link between stress and the experience of CSU symptoms. In light of these findings, our study offers a stress management intervention for individuals diagnosed with CSU.
Read full original descriptionShow less
The intervention consists of a 6-week online course designed to cultivate effective stress management techniques, referred to as 'attention-based training (ABT).' The course asks each participant to develop their own ABT practice, along with a one-hour session per week, providing techniques that participants can use to combat stressors related to their condition.
The 20 groups in the trial
- 1Treatment being tested
6 Week ABT intervention as described.
Treatment: ABT Online Programme
- 2Treatment being tested
6 Week ABT intervention as described.
Treatment: ABT Online Programme
- 3Treatment being tested
6 Week ABT intervention as described.
Treatment: ABT Online Programme
- 4Treatment being tested
6 Week ABT intervention as described.
Treatment: ABT Online Programme
- 5Treatment being tested
6 Week ABT intervention as described.
Treatment: ABT Online Programme
- 6Existing treatment, for comparison
Delayed intervention group
Treatment: Delayed Control group
- 7Existing treatment, for comparison
Delayed intervention group
Treatment: Delayed Control group
- 8Existing treatment, for comparison
Delayed intervention group
Treatment: Delayed Control group
- 9Existing treatment, for comparison
Delayed intervention group
Treatment: Delayed Control group
- 10Existing treatment, for comparison
Delayed intervention group
Treatment: Delayed Control group
- 11Treatment being tested
ABT intervention as described
Treatment: ABT Online Programme
- 12Treatment being tested
ABT intervention as described
Treatment: ABT Online Programme
- 13Treatment being tested
ABT intervention as described
Treatment: ABT Online Programme
- 14Treatment being tested
ABT intervention as described
Treatment: ABT Online Programme
- 15Treatment being tested
ABT intervention as described
Treatment: ABT Online Programme
- 16Existing treatment, for comparison
Delayed Control group
Treatment: Delayed Control group
- 17Existing treatment, for comparison
Delayed Control group
Treatment: Delayed Control group
- 18Existing treatment, for comparison
Delayed Control group
Treatment: Delayed Control group
- 19Existing treatment, for comparison
Delayed Control group
Treatment: Delayed Control group
- 20Existing treatment, for comparison
Delayed Control group
Treatment: Delayed Control group
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 31 October 2023